Response to 'Correspondence on "Results of a 1-year randomized double-blind placebo-controlled trial with methotrexate 25 mg/week in recently diagnosed polymyalgia rheumatica" by Bolhuis TE et al'.

Kooijman NESEP, Broeder ND, den Broeder AA, van der Maas A

Open source

DOI
10.1016/j.ard.2026.05.027
Published
2026 Sep
Container
Annals of the rheumatic diseases
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ard.2026.05.027,
  title = {Response to 'Correspondence on "Results of a 1-year randomized double-blind placebo-controlled trial with methotrexate 25 mg/week in recently diagnosed polymyalgia rheumatica" by Bolhuis TE et al'.},
  author = {Kooijman NESEP and Broeder ND and den Broeder AA and van der Maas A},
  year = {2026},
  journal = {Annals of the rheumatic diseases},
  doi = {10.1016/j.ard.2026.05.027},
  url = {https://doi.org/10.1016/j.ard.2026.05.027}
}

RIS

TY  - JOUR
TI  - Response to 'Correspondence on "Results of a 1-year randomized double-blind placebo-controlled trial with methotrexate 25 mg/week in recently diagnosed polymyalgia rheumatica" by Bolhuis TE et al'.
AU  - Kooijman NESEP
AU  - Broeder ND
AU  - den Broeder AA
AU  - van der Maas A
PY  - 2026
JO  - Annals of the rheumatic diseases
DO  - 10.1016/j.ard.2026.05.027
UR  - https://doi.org/10.1016/j.ard.2026.05.027
ER  - 

APA

NESEP, K., ND, B., AA, D. B., & A, V. D. M. (2026). Response to 'Correspondence on "Results of a 1-year randomized double-blind placebo-controlled trial with methotrexate 25 mg/week in recently diagnosed polymyalgia rheumatica" by Bolhuis TE et al'.. Annals of the rheumatic diseases. https://doi.org/10.1016/j.ard.2026.05.027

Source records